Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial
- PDF / 988,129 Bytes
- 15 Pages / 595.276 x 790.866 pts Page_size
- 13 Downloads / 204 Views
RESEARCH ARTICLE
Impact of a pharmacist‑administered deprescribing intervention on nursing home residents: a randomized controlled trial Cathy Balsom1 · Nicole Pittman1 · Renee King2 · Debbie Kelly1 Received: 30 November 2019 / Accepted: 28 May 2020 © Springer Nature Switzerland AG 2020
Abstract Background Polypharmacy is prevalent among long-term care residents in Canada, with 48.4% receiving ten or more different medications and 40.7% chronically prescribed potentially inappropriate medications. Objective We implemented a pharmacist-administered deprescribing program in a long-term care facility to determine if the number of medications taken per resident could be reduced. Setting: A long-term care facility in Newfoundland and Labrador, Canada from February 2017 to February 2018. Method: Residents were randomized to receive either a deprescribing-focused medication review by a pharmacist or usual care. Main outcome measure Change in the number of medications at 3 and 6 months. Results Fortyfive residents enrolled in the study (n = 22 intervention, n = 23 control). Seventy-eight deprescribing recommendations were made, and 85.1% were successfully implemented. The average number of medications taken by residents in the intervention group was 2.68 less than the control group (p
Data Loading...
